Published works by Robin Blaney

Published works

• EU Announces Political Agreement on Pharma Law Review

  Global Policy Watch · December 15, 2025

  LEX-WK-JKXQ6PN2
• EU Announces Political Agreement on Pharma Law Review

  Inside EU Life Sciences · December 11, 2025

  LEX-WK-XCJ47X9Y
• The Covington European Life Sciences Symposium 2025

  Inside EU Life Sciences · February 4, 2025

  LEX-WK-G2ZHTGPJ
• EMA Clinical Data Publication Policy to Cover All New Marketing Authorization Applications, Line Extensions and Major Clinical Type II Variations Starting Q2 2025

  Global Policy Watch · November 27, 2024

  LEX-WK-3M84XAW7
• EMA Clinical Data Publication Policy to Cover All New Marketing Authorization Applications, Line Extensions and Major Clinical Type II Variations Starting Q2 2025

  Inside EU Life Sciences · November 27, 2024

  LEX-WK-FW3YXVTT
• New ABPI Code and PMCPA Constitution and Procedure Published

  Inside EU Life Sciences · October 1, 2024

  LEX-WK-KFFES8J4
• European Parliament adopts its Position on EU Pharma Law Review: 8 Key Takeaways for Industry

  Inside EU Life Sciences · April 16, 2024

  LEX-WK-1ZSJ2N3A
• UK HRA Consults on a New Model Investigator-Initiated Study Agreement

  Inside EU Life Sciences · April 5, 2024

  LEX-WK-EEJ6VWRW
• Consultation on Changes to the ABPI Code and UK Advertising Complaints Process

  Inside EU Life Sciences · January 3, 2024

  LEX-WK-BXG24F0F
• UK Government Consults on Proposals Mandating the Disclosure of Industry Payments to the Healthcare Sector

  Inside EU Life Sciences · October 19, 2023

  LEX-WK-0T7VXQWS
• EU Talking Life Sciences Audiocast: Clinical Trial Transparency Requirements in the EU

  Inside EU Life Sciences · June 29, 2023

  LEX-WK-R2SD5QMP
• Update on the VPAS Judicial Review brought by the British Generic Manufacturers Association

  Inside EU Life Sciences · June 1, 2023

  LEX-WK-RE58NFZ5
• EU Pharma Legislation Review Series: Decentralized Manufacturing

  Inside EU Life Sciences · May 3, 2023

  LEX-WK-A90VYWR4
• EU Pharma Legislation Review Series: Supply Security and Shortages Control

  Global Policy Watch · May 2, 2023

  LEX-WK-VC9FHGCY
• EU Pharma Legislation Review Series: Supply Security and Shortages Control

  Inside EU Life Sciences · May 2, 2023

  LEX-WK-NPBD3SWG
• EU Pharma Legislation Review Series: Bolar Exemption under Patent Rights

  Inside EU Life Sciences · May 2, 2023

  LEX-WK-Z2EM53C6
• EU Pharma Legislation Review Series: Regulatory Data Protection

  Inside EU Life Sciences · April 26, 2023

  LEX-WK-D5JAPH26
• EU Talking Life Sciences Audiocast: Episode 4 – EU and UK Pharmaceutical Regulation of Tax Structures and Financial Flows – Implications for Global Supply Chains

  Inside EU Life Sciences · April 20, 2023

  LEX-WK-SSHKE7QZ
• Legislative Proposals for Clinical Trials Aim to Streamline, Simplify and Stimulate UK-based Innovation

  Inside EU Life Sciences · April 17, 2023

  LEX-WK-T650106N
• UK PMCPA Publishes First Ever Guidance to Pharmaceutical Companies about Social Media

  Inside EU Life Sciences · January 30, 2023

  LEX-WK-HCJTGAXA
• IFPMA and EFPIA Publish New Joint Guidance Note on Social Media and Digital Channels

  Inside EU Life Sciences · September 29, 2022

  LEX-WK-H4VDHDHY
• EMA Publishes Guidance on Clinical Trial Conduct During COVID-19 Pandemic

  Inside EU Life Sciences · March 25, 2020

  LEX-WK-BACX9TD9
• Proposed EU Rules Impact Commercial Testing Laboratories

  Inside EU Life Sciences · December 21, 2012

  LEX-WK-4Y7JB9A4
• New EU Regulations for Medical Devices and IVDs

  Inside EU Life Sciences · November 30, 2012

  LEX-WK-PF76M4HM
• Key Considerations for European M&A in the Life Sciences Sector

  Inside EU Life Sciences · March 5, 2012

  LEX-WK-QZNXMTVQ